Medartis Holding AG (MDRSF) Discusses Strategy Roadmap and Innovation in Upper Extremities and Hand Products June 4, 2026 3:00 AM EDT
Company Participants
Matthias Schupp – CEO & Member of the Executive Management Board
Marc Ammann – Executive Vice President of R&D and Innovation and Member of the Executive Management Board
Daniel Herren
Fabian Hildbrand
Peter Hackel – CFO & Member of Executive Management Board
Mario Della Cassa
Conference Call Participants
Sandra Dietschy – Octavian AG, Research Division
Daniel Jelovcan – Zürcher Kantonalbank, Research Division
Edward Hall – Stifel, Nicolaus & Company, Incorporated, Research Division
Presentation
Matthias Schupp
CEO & Member of the Executive Management Board
Okay. So, good morning, everybody. Maybe we can take a seat. You can put down a little bit of volume. We are not so many people. Yes. Again, welcome to now, rainy Basel. The sun from yesterday is gone. But I’m very happy that you made it to our investor and media event around the FESSH, the world’s biggest hand congress. And I’m so surprised to look what Fabian — I love it when Fabian has also here our products on the table. And by the way, the sexy nail is here. Some people who discussed yesterday night with me, they know about the sexy nail. It’s our brand-new launch for the U.S. some are looking at what we are doing. Is this becoming an erotic shop? No. Medartis is just becoming disruptive, different. And I hope you see this also throughout the FESSH. We have my road map, my strategy road map, a little bit where do we stand by end of May. Then I think very interesting for you at 10:00 around with Marc Ammann, our EVP, Innovation, Digitalization, Research and Development. Marc speaking about our road map and the sexy nail. And then I’m very happy to welcome Daniel Herren, Dr. Daniel Herren from the Schulthess Clinic in Zurich. He’s sitting there. And we thought we should invite the pope of CMC1 Prosthesis because you are not only placed, I don’t know how many you will discuss it. You will
